Faruqi & Faruqi Updates DENTSPLY SIRONA Investors on Class Action Lawsuit

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $75,000 in Dentsply between February 28, 2022, and November 6, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

You may also click here for additional information

NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ("Dentsply") and reminds investors of the January 27, 2025 deadline to apply for the role of lead plaintiff in a federal securities class action that has been initiated against the Company.

Faruqi & Faruqi, established in 1995, has successfully recovered hundreds of millions of dollars for investors and has offices in New York, Pennsylvania, California, and Georgia.

The allegations outlined in the complaint state that the Company and its executives breached federal securities laws by issuing false or misleading statements and neglecting to reveal important facts, such as: (1) Dentsply focused on low-income individuals lacking proper oral hygiene education or dental insurance, which often resulted in patients signing up for Byte despite having untreated dental issues; (2) the push for Byte's growth resulted in sales staff marketing to unsuitable patients; (3) as a consequence, the Byte patient onboarding process failed to ensure that ineligible patients did not receive treatment; (4) throughout and prior to the Class Period, numerous reports of injuries involving Byte patients began to surface; (5) Dentsply was aware of severe patient injuries caused by Byte for years but took little action to investigate or inform the FDA; (6) the Company lacked procedures to inform the FDA of these injuries, which they are legally obligated to do within 30 days upon learning of such incidents; (7) there was a noticeable spike in serious injury reports from Byte users reaching the FDA; (8) as a result, Dentsply significantly inflated the goodwill value of Byte; (9) consequently, the Company’s positive remarks about its business and outlook were materially misleading or lacked reasonable basis at all pertinent times.

The situation began to unravel after market hours on October 24, 2024, when Dentsply announced its decision to lawsuit, investors, Dentsply